Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Dreicer, MD, FACP
The Cleveland Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
76 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mbccop - San Juan
San Juan, Puerto Rico
- Veterans Affairs Medical Center - San Juan
San Juan, Puerto Rico
- Pretoria Academic Hospitals
Pretoria, South Africa
- Ccop - Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Cancer Center and Beckman Research Institute, City of Hope
Duarte, California, United States
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Ccop - Colorado Cancer Research Program, Inc.
Denver, Colorado, United States
- Ccop - Christiana Care Health Services
Wilmington, Delaware, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- Veterans Affairs Medical Center - Gainsville
Gainesville, Florida, United States
- Veterans Affairs Medical Center - Tampa (haley)
Tampa, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Veterans Affairs Medical Center - Indianapolis (roudebush)
Indianapolis, Indiana, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Mbccop - Lsu Health Sciences Center
New Orleans, Louisiana, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- New England Medical Center Hospital
Boston, Massachusetts, United States
- Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Duluth
Duluth, Minnesota, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Veterans Affairs Medical Center - Minneapolis
Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Ccop - Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- Veterans Affairs Medical Center - East Orange
East Orange, New Jersey, United States
- Trinitas Hospital - Jersey Street Campus
Elizabeth, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Feb 2000
- Primary completion
- 31 Oct 2002
- Completion
- —
- Last update posted
- 18 Jun 2023
- Registered enrollment
- —
- Registry id
- NCT00004223
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.